A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume.
| Member | Definition | Class |
|---|
| 4-hydroxyphenylethanol | A phenol substituted at position 4 by a 2-hydroxyethyl group. | 2-(4-hydroxyphenyl)ethanol |
| aica ribonucleotide | A 1-(phosphoribosyl)imidazolecarboxamide that is acadesine in which the hydroxy group at the 5' position has been converted to its monophosphate derivative. | AICA ribonucleotide |
| amiodarone | A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias. | amiodarone |
| arginine vasopressin | The predominant form of mammalian vasopressin (antidiuretic hormone). It is a nonapeptide containing an arginine at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. | argipressin |
| bl 4162a | A 1,5-dihydroimidazo[2,1-]quinazoline having an oxo substituent at the 2-position and chloro substituents at the 6- and 7-positions. | anagrelide |
| carpaine | An alkaloid that forms a major component of the papaya leaves and has been shown to exhibit cardiovascular effects. | carpaine |
| carvedilol | A member of the class of carbazoles that is an adrenergic antagonist with non-selective beta- and alpha-1 receptor blocking properties which helps in the management of congestive heart failure. | carvedilol |
| cilnidipine | A diesterified 1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium channel blocker, it is used as an antihypertensive. | cilnidipine |
| dexrazoxane | | (+)-dexrazoxane |
| ketanserin | A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group. | ketanserin |
| khellin | A furanochrome in which the basic tricyclic skeleton is substituted at positions 4 and 9 with methoxy groups and at position 7 with a methyl group. A major constituent of the plant Ammi visnaga it is a herbal folk medicine used for various illnesses, its main effect being as a vasodilator. | khellin |
| magnesium sulfate | A magnesium salt having sulfate as the counterion. | magnesium sulfate |
| nimodipine | A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm. | nimodipine |
| perhexiline | | perhexiline |
| probucol | A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood. | probucol |
| u 62840 | | treprostinil |
| vorapaxar | A carbamate ester that is the ethyl ester of [(1R,3aR,4aR,6R,8aR,9S,9aS)-9-{(E)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethynyl}-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl]carbamic acid. A protease-activated receptor-1 antagonist used (as its sulfate salt) for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or with peripheral arterial disease. It has been shown to reduce the rate of a combined endpoint of cardiovascular death, MI, stroke and urgent coronary revascularisation. | vorapaxar |
| zomepirac | | zomepirac |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 20.6706 | 1 | 4 |
| acetylcholinesterase | Homo sapiens (human) | Potency | 27.0197 | 2 | 3 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 26.8325 | 1 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 8.0704 | 1 | 5 |
| AR protein | Homo sapiens (human) | Potency | 24.7496 | 6 | 13 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 1.4144 | 2 | 6 |
| arylsulfatase A | Homo sapiens (human) | Potency | 1.9542 | 1 | 3 |
| ATAD5 protein, partial | Homo sapiens (human) | Potency | 21.5987 | 3 | 8 |
| Ataxin-2 | Homo sapiens (human) | Potency | 26.1061 | 2 | 4 |
| ATP-dependent phosphofructokinase | Trypanosoma brucei brucei TREU927 | Potency | 21.8122 | 1 | 3 |
| ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 26.6032 | 1 | 1 |
| Bloom syndrome protein isoform 1 | Homo sapiens (human) | Potency | 17.7828 | 2 | 2 |
| bromodomain adjacent to zinc finger domain 2B | Homo sapiens (human) | Potency | 52.2932 | 1 | 4 |
| caspase 7, apoptosis-related cysteine protease | Homo sapiens (human) | Potency | 33.4915 | 1 | 1 |
| caspase-3 | Homo sapiens (human) | Potency | 33.4915 | 1 | 1 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 20.9602 | 1 | 4 |
| cellular tumor antigen p53 isoform a | Homo sapiens (human) | Potency | 10.0000 | 2 | 2 |
| Chain A, 2-oxoglutarate Oxygenase | Homo sapiens (human) | Potency | 25.1189 | 1 | 1 |
| Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 12.7829 | 2 | 4 |
| Chain A, Cruzipain | Trypanosoma cruzi | Potency | 39.8107 | 1 | 2 |
| Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 26.9680 | 2 | 2 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 9.8528 | 1 | 3 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | Homo sapiens (human) | Potency | 63.5144 | 1 | 2 |
| chromobox protein homolog 1 | Homo sapiens (human) | Potency | 43.6472 | 2 | 6 |
| cytochrome P450 2C19 precursor | Homo sapiens (human) | Potency | 3.7619 | 1 | 2 |
| cytochrome P450 2C9 precursor | Homo sapiens (human) | Potency | 1.3507 | 1 | 3 |
| cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 6.8602 | 1 | 6 |
| cytochrome P450 2D6 | Homo sapiens (human) | Potency | 11.1457 | 1 | 5 |
| cytochrome P450 2D6 isoform 1 | Homo sapiens (human) | Potency | 20.8114 | 1 | 2 |
| cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 9.7560 | 2 | 10 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 8.7753 | 2 | 5 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 29.8493 | 1 | 1 |
| D(1A) dopamine receptor | Homo sapiens (human) | Potency | 5.9014 | 2 | 5 |
| D(1A) dopamine receptor | Sus scrofa (pig) | Potency | 13.8905 | 1 | 2 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 50.1187 | 1 | 1 |
| dopamine D1 receptor | Homo sapiens (human) | Potency | 0.0073 | 1 | 1 |
| endonuclease IV | Escherichia coli | Potency | 11.2202 | 1 | 1 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 26.7701 | 6 | 10 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 18.5970 | 1 | 2 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 20.3210 | 9 | 28 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 22.3501 | 1 | 8 |
| EWS/FLI fusion protein | Homo sapiens (human) | Potency | 13.1413 | 4 | 23 |
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 22.0237 | 3 | 5 |
| flap endonuclease 1 | Homo sapiens (human) | Potency | 2.9935 | 1 | 1 |
| Fumarate hydratase | Homo sapiens (human) | Potency | 25.6296 | 1 | 5 |
| G | Vesicular stomatitis virus | Potency | 6.8602 | 1 | 6 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 9.3810 | 1 | 6 |
| GALC protein | Homo sapiens (human) | Potency | 0.6310 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 9.3810 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 9.3810 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 9.3810 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 9.3810 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 9.3810 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 9.3810 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 9.3810 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 9.3810 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 9.3810 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 9.3810 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 9.3810 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 9.3810 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 9.3810 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 9.3810 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 9.3810 | 1 | 6 |
| geminin | Homo sapiens (human) | Potency | 14.7959 | 3 | 8 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 15.2293 | 2 | 6 |
| glp-1 receptor, partial | Homo sapiens (human) | Potency | 11.2202 | 1 | 2 |
| GLS protein | Homo sapiens (human) | Potency | 5.4415 | 2 | 3 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 14.2092 | 3 | 7 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 29.8493 | 1 | 1 |
| GTP-binding nuclear protein Ran isoform 1 | Homo sapiens (human) | Potency | 20.5962 | 1 | 1 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 23.7083 | 1 | 1 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | Potency | 2.5494 | 2 | 11 |
| histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 0.3162 | 1 | 1 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 58.9093 | 2 | 3 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | Homo sapiens (human) | Potency | 25.1189 | 1 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 6.8602 | 1 | 6 |
| huntingtin isoform 2 | Homo sapiens (human) | Potency | 28.9342 | 1 | 2 |
| hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 23.5317 | 2 | 3 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Homo sapiens (human) | Potency | 31.6228 | 2 | 2 |
| importin subunit beta-1 isoform 1 | Homo sapiens (human) | Potency | 20.5962 | 1 | 1 |
| Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 6.8602 | 1 | 12 |
| Integrin alpha-IIb | Homo sapiens (human) | Potency | 10.0000 | 1 | 1 |
| Integrin beta-3 | Homo sapiens (human) | Potency | 10.0000 | 1 | 1 |
| Interferon beta | Homo sapiens (human) | Potency | 17.3652 | 3 | 16 |
| lamin isoform A-delta10 | Homo sapiens (human) | Potency | 4.4943 | 1 | 5 |
| lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 15.8489 | 1 | 1 |
| lysosomal alpha-glucosidase preproprotein | Homo sapiens (human) | Potency | 11.2202 | 2 | 2 |
| M-phase phosphoprotein 8 | Homo sapiens (human) | Potency | 28.1838 | 1 | 1 |
| Microtubule-associated protein tau | Homo sapiens (human) | Potency | 20.3329 | 2 | 5 |
| mitogen-activated protein kinase 1 | Homo sapiens (human) | Potency | 24.9765 | 2 | 3 |
| muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Potency | 17.7828 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 11.2202 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 11.2202 | 1 | 1 |
| neuropeptide S receptor isoform A | Homo sapiens (human) | Potency | 1.5849 | 1 | 1 |
| NFKB1 protein, partial | Homo sapiens (human) | Potency | 3.5481 | 2 | 2 |
| nonstructural protein 1 | Influenza A virus (A/WSN/1933(H1N1)) | Potency | 28.7968 | 1 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 19.6213 | 2 | 5 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 7.2461 | 1 | 2 |
| nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 16.5508 | 2 | 9 |
| nuclear receptor subfamily 1, group I, member 2 | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1 | 1 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 13.8949 | 3 | 9 |
| Parkin | Homo sapiens (human) | Potency | 3.6166 | 1 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Potency | 4.5158 | 1 | 2 |
| peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 11.5188 | 1 | 5 |
| peripheral myelin protein 22 isoform 1 | Homo sapiens (human) | Potency | 75.6863 | 1 | 1 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 20.3339 | 3 | 5 |
| peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 27.8795 | 2 | 3 |
| phosphopantetheinyl transferase | Bacillus subtilis | Potency | 25.3152 | 1 | 3 |
| plasminogen precursor | Mus musculus (house mouse) | Potency | 14.6892 | 1 | 1 |
| polyprotein | Zika virus | Potency | 25.6296 | 1 | 5 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | Potency | 7.9433 | 1 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | Homo sapiens (human) | Potency | 7.2774 | 1 | 3 |
| PPM1D protein | Homo sapiens (human) | Potency | 23.6791 | 1 | 6 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 4.3340 | 2 | 4 |
| progesterone receptor | Homo sapiens (human) | Potency | 20.5586 | 2 | 4 |
| Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) | Potency | 56.2341 | 1 | 1 |
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 23.8140 | 2 | 5 |
| regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 0.5323 | 1 | 1 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 29.3743 | 3 | 6 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 9.5837 | 2 | 2 |
| serine/threonine-protein kinase mTOR isoform 1 | Homo sapiens (human) | Potency | 17.1480 | 2 | 4 |
| SMAD family member 2 | Homo sapiens (human) | Potency | 17.6936 | 2 | 3 |
| SMAD family member 3 | Homo sapiens (human) | Potency | 17.6936 | 2 | 3 |
| snurportin-1 | Homo sapiens (human) | Potency | 20.5962 | 1 | 1 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 8.5596 | 2 | 5 |
| survival motor neuron protein isoform d | Homo sapiens (human) | Potency | 13.1889 | 1 | 2 |
| TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 35.4813 | 1 | 1 |
| TDP1 protein | Homo sapiens (human) | Potency | 21.0923 | 2 | 17 |
| thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 18.6666 | 3 | 5 |
| Thrombopoietin | Homo sapiens (human) | Potency | 25.1189 | 2 | 2 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 16.1855 | 2 | 5 |
| thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 5.6234 | 1 | 1 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 20.2087 | 5 | 5 |
| urokinase plasminogen activator surface receptor precursor | Mus musculus (house mouse) | Potency | 14.6892 | 1 | 1 |
| urokinase-type plasminogen activator precursor | Mus musculus (house mouse) | Potency | 14.6892 | 1 | 1 |
| USP1 protein, partial | Homo sapiens (human) | Potency | 39.1469 | 2 | 8 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 6.0070 | 1 | 1 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 19.4104 | 2 | 4 |
| vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 89.1251 | 1 | 2 |
| Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 29.8493 | 1 | 1 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | Homo sapiens (human) | Ki | 0.0250 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | IC50 | 0.6686 | 3 | 3 |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | Ki | 0.0035 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | Ki | 0.0032 | 2 | 2 |
| 5-hydroxytryptamine receptor 1B | Homo sapiens (human) | IC50 | 8.2500 | 2 | 2 |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | IC50 | 0.0058 | 1 | 1 |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | Ki | 0.9517 | 2 | 2 |
| 5-hydroxytryptamine receptor 1D | Homo sapiens (human) | IC50 | 3.5100 | 3 | 3 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | IC50 | 0.2386 | 17 | 18 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | IC50 | 0.0021 | 4 | 4 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | Ki | 0.0830 | 13 | 14 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | Ki | 0.0033 | 17 | 17 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | IC50 | 0.4120 | 2 | 3 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | IC50 | 0.0016 | 3 | 3 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | Ki | 0.2607 | 2 | 3 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | Ki | 0.0068 | 6 | 6 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | IC50 | 0.1739 | 2 | 3 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | IC50 | 0.0016 | 3 | 3 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | Ki | 0.1039 | 3 | 4 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | Ki | 0.0129 | 7 | 7 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | IC50 | 0.2595 | 1 | 2 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | Ki | 0.1360 | 1 | 2 |
| 5-hydroxytryptamine receptor 5A | Homo sapiens (human) | Ki | 20.0000 | 2 | 2 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | IC50 | 10.4800 | 1 | 2 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | Ki | 4.1770 | 2 | 3 |
| 5-hydroxytryptamine receptor 7 | Cavia porcellus (domestic guinea pig) | Ki | 0.0035 | 1 | 1 |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | Ki | 1.2965 | 2 | 2 |
| 5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | Ki | 0.0035 | 1 | 1 |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | Ki | 44.3000 | 1 | 1 |
| Adenosine receptor A3 | Homo sapiens (human) | IC50 | 17.5470 | 1 | 1 |
| Adenosine receptor A3 | Homo sapiens (human) | Ki | 9.1940 | 2 | 2 |
| Albumin | Homo sapiens (human) | Ki | 109,648,000,000.0000 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | IC50 | 2.0344 | 1 | 3 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | Ki | 2.0173 | 1 | 3 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 8.7810 | 2 | 2 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 4.9640 | 2 | 2 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 8.7810 | 2 | 2 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 9.9180 | 1 | 1 |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | IC50 | 0.0018 | 1 | 1 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0150 | 1 | 1 |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | Ki | 0.0009 | 1 | 1 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | IC50 | 0.2090 | 1 | 2 |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 7.7625 | 1 | 1 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | Ki | 0.0785 | 1 | 2 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | IC50 | 6.4935 | 1 | 2 |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 7.7625 | 1 | 1 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | Ki | 2.9645 | 1 | 2 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | IC50 | 0.0900 | 1 | 1 |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 7.7625 | 1 | 1 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | Ki | 0.0130 | 1 | 1 |
| Amyloid-beta precursor protein | Homo sapiens (human) | IC50 | 30.0000 | 1 | 1 |
| Androgen receptor | Rattus norvegicus (Norway rat) | IC50 | 42.2480 | 1 | 1 |
| Androgen receptor | Rattus norvegicus (Norway rat) | Ki | 28.1650 | 1 | 1 |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | IC50 | 4.1193 | 1 | 1 |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | Ki | 3.3749 | 1 | 1 |
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 5 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | IC50 | 17.0600 | 5 | 5 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | Ki | 4.4900 | 2 | 2 |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | Ki | 7.4000 | 2 | 2 |
| B2 bradykinin receptor | Homo sapiens (human) | IC50 | 12.9660 | 1 | 1 |
| B2 bradykinin receptor | Homo sapiens (human) | Ki | 7.6740 | 1 | 1 |
| Beta-1 adrenergic receptor | Homo sapiens (human) | IC50 | 21.8216 | 1 | 2 |
| Beta-1 adrenergic receptor | Homo sapiens (human) | Ki | 12.6011 | 1 | 2 |
| Beta-2 adrenergic receptor | Homo sapiens (human) | IC50 | 0.0002 | 1 | 1 |
| Beta-2 adrenergic receptor | Homo sapiens (human) | Ki | 0.0002 | 1 | 1 |
| Beta-3 adrenergic receptor | Homo sapiens (human) | IC50 | 21.1766 | 1 | 2 |
| Beta-3 adrenergic receptor | Homo sapiens (human) | Ki | 15.8821 | 1 | 2 |
| Beta-carbonic anhydrase 1 | Mycobacterium tuberculosis H37Rv | Ki | 0.8500 | 1 | 1 |
| Bifunctional purine biosynthesis protein ATIC | Homo sapiens (human) | IC50 | 25.0000 | 1 | 1 |
| Bile acid receptor | Homo sapiens (human) | IC50 | 8.9600 | 1 | 1 |
| Bile salt export pump | Homo sapiens (human) | IC50 | 158.7050 | 4 | 12 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | IC50 | 13.7000 | 1 | 1 |
| C-8 sterol isomerase | Saccharomyces cerevisiae S288C | Ki | 0.0620 | 1 | 1 |
| C-C chemokine receptor type 2 | Homo sapiens (human) | IC50 | 11.0860 | 1 | 1 |
| C-C chemokine receptor type 2 | Homo sapiens (human) | Ki | 4.2850 | 1 | 1 |
| C-C chemokine receptor type 4 | Homo sapiens (human) | IC50 | 21.7730 | 1 | 1 |
| C-C chemokine receptor type 4 | Homo sapiens (human) | Ki | 11.4050 | 1 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Homo sapiens (human) | IC50 | 1.2430 | 1 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | IC50 | 7.1500 | 1 | 1 |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 5 |
| Cannabinoid receptor 1 | Homo sapiens (human) | IC50 | 1.7360 | 1 | 1 |
| Cannabinoid receptor 1 | Homo sapiens (human) | Ki | 1.3710 | 1 | 1 |
| Carbonic anhydrase | Candida albicans SC5314 | Ki | 1.1000 | 1 | 1 |
| Carbonic anhydrase | Cryptococcus neoformans var. grubii | Ki | 1.0800 | 1 | 1 |
| Carbonic anhydrase | Mycobacterium tuberculosis H37Rv | Ki | 12.1000 | 1 | 1 |
| Carbonic anhydrase 1 | Homo sapiens (human) | Ki | 430.0000 | 1 | 1 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Ki | 8.7000 | 1 | 1 |
| Carnitine O-palmitoyltransferase 1, liver isoform | Homo sapiens (human) | IC50 | 106.3333 | 2 | 3 |
| Carnitine O-palmitoyltransferase 1, liver isoform | Rattus norvegicus (Norway rat) | IC50 | 112.5000 | 2 | 2 |
| Carnitine O-palmitoyltransferase 1, muscle isoform | Homo sapiens (human) | IC50 | 100.0000 | 1 | 2 |
| Carnitine O-palmitoyltransferase 1, muscle isoform | Rattus norvegicus (Norway rat) | IC50 | 11.0000 | 1 | 1 |
| Carnitine O-palmitoyltransferase 2, mitochondrial | Homo sapiens (human) | IC50 | 86.4000 | 1 | 2 |
| Carnitine O-palmitoyltransferase 2, mitochondrial | Rattus norvegicus (Norway rat) | IC50 | 79.0000 | 1 | 1 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | IC50 | 34.0000 | 2 | 2 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | IC50 | 0.2327 | 6 | 6 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | IC50 | 0.2327 | 6 | 6 |
| Cytochrome P450 1A1 | Homo sapiens (human) | IC50 | 4.0200 | 1 | 1 |
| Cytochrome P450 1A1 | Homo sapiens (human) | Ki | 3.8000 | 1 | 1 |
| Cytochrome P450 1A2 | Homo sapiens (human) | IC50 | 0.0400 | 1 | 1 |
| Cytochrome P450 1A2 | Homo sapiens (human) | Ki | 0.0310 | 1 | 1 |
| Cytochrome P450 1B1 | Homo sapiens (human) | IC50 | 17.8500 | 2 | 2 |
| Cytochrome P450 2C19 | Homo sapiens (human) | IC50 | 7.0000 | 2 | 2 |
| Cytochrome P450 2C8 | Homo sapiens (human) | Ki | 1.5000 | 1 | 1 |
| Cytochrome P450 2C9 | Homo sapiens (human) | IC50 | 16.0950 | 3 | 4 |
| Cytochrome P450 2D6 | Homo sapiens (human) | IC50 | 5.4704 | 2 | 2 |
| Cytochrome P450 2J2 | Homo sapiens (human) | IC50 | 26.6900 | 1 | 2 |
| Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| D | Rattus norvegicus (Norway rat) | IC50 | 7.7625 | 1 | 1 |
| D | Rattus norvegicus (Norway rat) | Ki | 3.0000 | 1 | 1 |
| D(1A) dopamine receptor | Homo sapiens (human) | IC50 | 5.3200 | 1 | 2 |
| D(1A) dopamine receptor | Homo sapiens (human) | Ki | 2.6600 | 1 | 2 |
| D(2) dopamine receptor | Homo sapiens (human) | IC50 | 10.0490 | 1 | 2 |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | IC50 | 1.8000 | 2 | 2 |
| D(2) dopamine receptor | Homo sapiens (human) | Ki | 1.7359 | 3 | 4 |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | Ki | 0.7770 | 2 | 2 |
| D(3) dopamine receptor | Homo sapiens (human) | IC50 | 0.8925 | 1 | 2 |
| D(3) dopamine receptor | Homo sapiens (human) | Ki | 0.3030 | 1 | 2 |
| D(4) dopamine receptor | Homo sapiens (human) | IC50 | 17.7200 | 1 | 1 |
| D(4) dopamine receptor | Homo sapiens (human) | Ki | 3.1082 | 2 | 2 |
| Delta-type opioid receptor | Homo sapiens (human) | IC50 | 8.0140 | 1 | 1 |
| Delta-type opioid receptor | Homo sapiens (human) | Ki | 2.8250 | 1 | 1 |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
| DNA topoisomerase 2-beta | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Endothelin-1 receptor | Homo sapiens (human) | IC50 | 26.2880 | 1 | 1 |
| Endothelin-1 receptor | Homo sapiens (human) | Ki | 16.1770 | 1 | 1 |
| Epidermal growth factor receptor | Homo sapiens (human) | IC50 | 1.4852 | 1 | 1 |
| Fructose-1,6-bisphosphatase 1 | Homo sapiens (human) | IC50 | 12.0000 | 1 | 1 |
| Hepatocyte growth factor receptor | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.0100 | 1 | 1 |
| Histamine H1 receptor | Homo sapiens (human) | Ki | 0.0020 | 1 | 1 |
| Histamine H2 receptor | Homo sapiens (human) | IC50 | 10.5550 | 1 | 1 |
| Histamine H2 receptor | Homo sapiens (human) | Ki | 10.3790 | 1 | 1 |
| Histone lysine demethylase PHF8 | Homo sapiens (human) | IC50 | 252.0000 | 1 | 1 |
| Kappa-type opioid receptor | Homo sapiens (human) | IC50 | 16.6800 | 1 | 1 |
| Kappa-type opioid receptor | Homo sapiens (human) | Ki | 6.6720 | 1 | 1 |
| Lactoylglutathione lyase | Homo sapiens (human) | Ki | 259.1000 | 3 | 3 |
| Lethal factor | Bacillus anthracis | IC50 | 3.5000 | 1 | 1 |
| Lysine-specific demethylase 5A | Homo sapiens (human) | IC50 | 699.6667 | 3 | 3 |
| Lysine-specific demethylase 7A | Homo sapiens (human) | IC50 | 118.0000 | 2 | 2 |
| Lysine-specific demethylase PHF2 | Homo sapiens (human) | IC50 | 84.0000 | 1 | 1 |
| Melanocortin receptor 3 | Homo sapiens (human) | IC50 | 12.3720 | 1 | 1 |
| Melanocortin receptor 3 | Homo sapiens (human) | Ki | 10.7970 | 1 | 1 |
| Melanocortin receptor 4 | Homo sapiens (human) | IC50 | 13.7550 | 1 | 1 |
| Melanocortin receptor 4 | Homo sapiens (human) | Ki | 13.2260 | 1 | 1 |
| Melanocortin receptor 5 | Homo sapiens (human) | IC50 | 9.4970 | 1 | 1 |
| Melanocortin receptor 5 | Homo sapiens (human) | Ki | 8.9090 | 1 | 1 |
| Mu-type opioid receptor | Homo sapiens (human) | IC50 | 19.0370 | 1 | 1 |
| Mu-type opioid receptor | Homo sapiens (human) | Ki | 7.7280 | 1 | 1 |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | IC50 | 92.4000 | 1 | 1 |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 5 |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | IC50 | 2.6618 | 1 | 2 |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | Ki | 0.6409 | 1 | 2 |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | IC50 | 5.0800 | 1 | 1 |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | Ki | 1.8060 | 1 | 1 |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | IC50 | 3.1598 | 1 | 2 |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | Ki | 0.6700 | 1 | 2 |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | IC50 | 3.6110 | 1 | 2 |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | Ki | 0.5034 | 1 | 2 |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | IC50 | 1.2961 | 1 | 2 |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | Ki | 0.9312 | 1 | 2 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | IC50 | 1.6000 | 1 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | IC50 | 4.1193 | 1 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | Ki | 3.3749 | 1 | 1 |
| Oxytocin receptor | Homo sapiens (human) | Ki | 0.0047 | 5 | 5 |
| Oxytocin receptor | Rattus norvegicus (Norway rat) | Ki | 0.0012 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Potassium channel subfamily K member 10 | Homo sapiens (human) | IC50 | 15.8000 | 2 | 2 |
| Potassium channel subfamily K member 2 | Homo sapiens (human) | IC50 | 10.9500 | 2 | 2 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | IC50 | 7.4185 | 10 | 17 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | Ki | 3.3749 | 1 | 1 |
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | IC50 | 15.0000 | 1 | 1 |
| Prostaglandin G/H synthase 2 | Bos taurus (cattle) | IC50 | 15.0000 | 1 | 1 |
| Proteinase-activated receptor 1 | Homo sapiens (human) | IC50 | 0.0626 | 8 | 8 |
| Proteinase-activated receptor 1 | Homo sapiens (human) | Ki | 0.0077 | 5 | 5 |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | IC50 | 9.1480 | 1 | 1 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | IC50 | 6.5300 | 2 | 2 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | IC50 | 148.0000 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | IC50 | 0.8991 | 2 | 3 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | Ki | 0.3781 | 2 | 3 |
| Sodium channel protein type 1 subunit alpha | Homo sapiens (human) | IC50 | 4.8000 | 1 | 1 |
| Sodium channel protein type 10 subunit alpha | Homo sapiens (human) | IC50 | 4.8000 | 1 | 1 |
| Sodium channel protein type 11 subunit alpha | Homo sapiens (human) | IC50 | 4.8000 | 1 | 1 |
| Sodium channel protein type 2 subunit alpha | Homo sapiens (human) | IC50 | 4.8000 | 1 | 1 |
| Sodium channel protein type 3 subunit alpha | Homo sapiens (human) | IC50 | 4.8000 | 1 | 1 |
| Sodium channel protein type 4 subunit alpha | Homo sapiens (human) | IC50 | 4.8000 | 1 | 1 |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | IC50 | 4.8000 | 1 | 1 |
| Sodium channel protein type 7 subunit alpha | Homo sapiens (human) | IC50 | 4.8000 | 1 | 1 |
| Sodium channel protein type 8 subunit alpha | Homo sapiens (human) | IC50 | 4.8000 | 1 | 1 |
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | IC50 | 4.8000 | 1 | 1 |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | IC50 | 7.7625 | 1 | 2 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | IC50 | 1.6750 | 1 | 2 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | Ki | 1.3305 | 1 | 2 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | IC50 | 2.0344 | 1 | 3 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | Ki | 4.0130 | 2 | 4 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | IC50 | 1.2630 | 1 | 2 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | Ki | 3.7807 | 2 | 3 |
| Solute carrier family 22 member 1 | Homo sapiens (human) | IC50 | 3.4000 | 1 | 1 |
| Solute carrier family 22 member 2 | Homo sapiens (human) | IC50 | 7.5000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A4 | Rattus norvegicus (Norway rat) | Ki | 1.8000 | 1 | 1 |
| Squalene monooxygenase | Homo sapiens (human) | IC50 | 12.0000 | 1 | 1 |
| Squalene synthase | Homo sapiens (human) | IC50 | 8.0000 | 1 | 1 |
| Substance-K receptor | Homo sapiens (human) | IC50 | 19.3150 | 1 | 1 |
| Substance-K receptor | Homo sapiens (human) | Ki | 6.4380 | 1 | 1 |
| Synaptic vesicular amine transporter | Homo sapiens (human) | IC50 | 0.1800 | 1 | 1 |
| Synaptic vesicular amine transporter | Homo sapiens (human) | Ki | 0.5400 | 3 | 3 |
| Thyroid hormone receptor alpha | Gallus gallus (chicken) | IC50 | 200.0000 | 1 | 1 |
| Thyroid hormone receptor alpha | Homo sapiens (human) | IC50 | 0.6500 | 1 | 1 |
| Thyroid hormone receptor beta | Homo sapiens (human) | IC50 | 0.6000 | 1 | 1 |
| Thyroid hormone receptor beta | Rattus norvegicus (Norway rat) | IC50 | 200.0000 | 1 | 1 |
| Toll-like receptor 4 | Homo sapiens (human) | IC50 | 32.2200 | 1 | 1 |
| Translocator protein | Mus musculus (house mouse) | Ki | 0.0004 | 1 | 2 |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | IC50 | 2.4405 | 1 | 2 |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | IC50 | 19.5000 | 2 | 2 |
| Vascular cell adhesion protein 1 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Vasopressin V1a receptor | Homo sapiens (human) | Ki | 0.0013 | 11 | 11 |
| Vasopressin V1b receptor | Homo sapiens (human) | Ki | 0.0011 | 3 | 3 |
| Vasopressin V1b receptor | Rattus norvegicus (Norway rat) | Ki | 0.0003 | 1 | 1 |
| Vasopressin V2 receptor | Homo sapiens (human) | IC50 | 0.2420 | 1 | 1 |
| Vasopressin V2 receptor | Homo sapiens (human) | Ki | 0.0090 | 4 | 4 |
| Vasopressin V2 receptor | Rattus norvegicus (Norway rat) | Ki | 0.0004 | 1 | 1 |
| Vesicular acetylcholine transporter | Rattus norvegicus (Norway rat) | Ki | 10.0000 | 1 | 1 |
| Voltage-dependent calcium channel gamma-1 subunit | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel gamma-3 subunit | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel gamma-4 subunit | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel gamma-5 subunit | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel gamma-6 subunit | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel gamma-7 subunit | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel gamma-8 subunit | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | Homo sapiens (human) | IC50 | 7.0149 | 2 | 2 |
| Voltage-dependent calcium channel subunit alpha-2/delta-2 | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-3 | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-4 | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Cavia porcellus (domestic guinea pig) | IC50 | 1.2440 | 3 | 5 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | IC50 | 4.9014 | 7 | 7 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Rattus norvegicus (Norway rat) | IC50 | 5.3000 | 1 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | IC50 | 5.3900 | 3 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | IC50 | 5.3900 | 3 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | IC50 | 5.3900 | 3 | 3 |
| Voltage-dependent L-type calcium channel subunit beta-1 | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit beta-2 | Homo sapiens (human) | IC50 | 7.0149 | 2 | 2 |
| Voltage-dependent L-type calcium channel subunit beta-3 | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit beta-4 | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | Homo sapiens (human) | IC50 | 16.9000 | 4 | 4 |
| Voltage-dependent P/Q-type calcium channel subunit alpha-1A | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent R-type calcium channel subunit alpha-1E | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1G | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1H | Homo sapiens (human) | IC50 | 19.0000 | 2 | 2 |
| Voltage-dependent T-type calcium channel subunit alpha-1I | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |